News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,436 Results
Type
Article (77754)
Company Profile (732)
Press Release (768931)
Multimedia
Podcasts (195)
Webinars (29)
Section
Business (229568)
Career Advice (3804)
Deals (39535)
Drug Delivery (151)
Drug Development (90151)
Employer Resources (205)
FDA (18221)
Job Trends (17281)
News (391466)
Policy (39218)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3015)
Academic (2)
Accelerated approval (36)
Adcomms (36)
Allergies (154)
Alliances (56464)
ALS (183)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (357)
Approvals (18405)
Artificial intelligence (613)
Autoimmune disease (178)
Automation (40)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (206)
Biotechnology (450)
Bladder cancer (164)
Brain cancer (66)
Breast cancer (678)
Cancer (5134)
Cardiovascular disease (453)
Career advice (3262)
Career pathing (42)
CAR-T (314)
CDC (60)
Celiac Disease (2)
Cell therapy (844)
Cervical cancer (38)
Clinical research (76197)
Collaboration (1879)
Company closure (5)
Compensation (1201)
Complete response letters (77)
COVID-19 (2996)
CRISPR (101)
C-suite (918)
Cystic fibrosis (155)
Data (6420)
Decentralized trials (2)
Denatured (73)
Depression (153)
Diabetes (540)
Diagnostics (7257)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (296)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (247)
Earnings (98311)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (134532)
Executive appointments (1051)
FDA (21475)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1582)
Gene editing (221)
Generative AI (61)
Gene therapy (688)
GLP-1 (1145)
Government (5435)
Grass and pollen (8)
Guidances (387)
Healthcare (20944)
HIV (65)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (301)
Immuno-oncology (66)
Indications (111)
Infectious disease (3297)
Inflammatory bowel disease (209)
Inflation Reduction Act (17)
Influenza (126)
Intellectual property (258)
Interviews (745)
IPO (17893)
IRA (61)
Job creations (5047)
Job search strategy (2639)
JPM (71)
Kidney cancer (17)
Labor market (97)
Layoffs (658)
Leadership (41)
Legal (10009)
Liver cancer (99)
Longevity (15)
Lung cancer (693)
Lymphoma (387)
Machine learning (44)
Management (66)
Manufacturing (875)
MASH (178)
Medical device (15039)
Medtech (15096)
Mergers & acquisitions (22730)
Metabolic disorders (1432)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (366)
Neuropsychiatric disorders (105)
Neuroscience (3165)
Neurotech (1)
NextGen: Class of 2026 (7664)
Non-profit (5118)
Now hiring (68)
Obesity (699)
Opinion (339)
Ovarian cancer (171)
Pain (219)
Pancreatic cancer (240)
Parkinson's disease (302)
Partnered (37)
Patents (522)
Patient recruitment (514)
Peanut (61)
People (66144)
Pharmaceutical (138)
Pharmacy benefit managers (33)
Phase 1 (23570)
Phase 2 (33186)
Phase 3 (25022)
Pipeline (5460)
Policy (344)
Postmarket research (3303)
Preclinical (10414)
Press Release (72)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (948)
Real estate (7261)
Recruiting (81)
Regulatory (28587)
Reports (69)
Research institute (2730)
Resumes & cover letters (592)
Rett syndrome (28)
RNA editing (21)
RSV (87)
Schizophrenia (162)
Series A (263)
Series B (204)
Service/supplier (27)
Sickle cell disease (105)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (49)
Startups (4251)
State (2)
Stomach cancer (20)
Supply chain (115)
Tariffs (101)
The Weekly (120)
Vaccines (1171)
Venture capital (100)
Weight loss (481)
Women's health (95)
Worklife (22)
Date
Today (31)
Last 7 days (547)
Last 30 days (2240)
Last 365 days (32258)
2026 (3794)
2025 (32705)
2024 (37932)
2023 (42566)
2022 (53928)
2021 (58723)
2020 (57665)
2019 (51317)
2018 (39100)
2017 (36915)
2016 (37887)
2015 (43902)
2014 (38729)
2013 (34881)
2012 (36713)
2011 (36809)
2010 (36472)
Location
Africa (1227)
Alabama (92)
Alaska (7)
Arizona (331)
Arkansas (14)
Asia (50344)
Australia (8624)
California (11785)
Canada (3375)
China (1202)
Colorado (501)
Connecticut (510)
Delaware (353)
Europe (114539)
Florida (1741)
Georgia (379)
Hawaii (4)
Idaho (67)
Illinois (966)
India (72)
Indiana (555)
Iowa (24)
Japan (448)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1475)
Massachusetts (8655)
Michigan (362)
Minnesota (673)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (86)
New Jersey (3167)
New Mexico (33)
New York (3111)
North Carolina (1630)
North Dakota (10)
Northern California (5672)
Ohio (358)
Oklahoma (23)
Oregon (53)
Pennsylvania (2349)
Puerto Rico (25)
Rhode Island (51)
South America (1592)
South Carolina (68)
South Dakota (1)
Southern California (4555)
Tennessee (179)
Texas (1845)
United States (42395)
Utah (353)
Vermont (1)
Virginia (294)
Washington D.C. (88)
Washington State (985)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
847,436 Results for "vetter pharma fertigung gmbh and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Press Releases
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems
January 15, 2026
·
1 min read
Press Releases
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
November 5, 2025
·
3 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Press Releases
Leadership Transition at Vetter: Thomas Otto Retires
December 3, 2025
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony
Pharmaceutical service provider expands its footprint in the greater Chicago area · Production site expected to be ready for media fill by the end of 2029 · Modern site with holistic approach for state-of-the-art manufacturing operations · Fulfills the requirements for increased capacity in early clinical filling
June 27, 2025
·
1 min read
Drug Pricing
Opinion: Pricing Transparency Is Coming to the Pharma Industry
Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.
February 2, 2026
·
5 min read
·
Joshua R. Mansbach
1 of 84,744
Next
